鐢㈠搧浠嬬垂锛�
Esco Isoclean 闅旈洟寮忓埗钘ユ搷浣滃畨鍏ㄦ煖锛堣矤澹撳瀷锛�, 鎻愪緵鍗遍毆鍝併€佺劇鑿岃棩鍝侀厤鍒朵竴鍊嬬鍚圲SP 797 瑕忔牸鐨勫畨鍏ㄥ拰娼斿噲鐠板銆�
鐩告瘮浜庨枊鏀惧紡鐨勬綌鍑堢┖姘ｈō鍌欙紝濡傝秴娼斿噲宸ヤ綔鑷哄拰浜岀礆鐢熺墿瀹夊叏鏌滐紝闅旈洟绯荤当鎻愪緵鏇村姞鍎秺鐨勯殧闆㈡€ц兘銆傛澶栵紝USP 797妯欐簴婧栧墖鎸囧畾闅旈洟鍣ㄦ洿閬╁悎鐢ㄤ簬涓€鍊嬭純灏戝彈鍒板毚鍘茬挵澧冩帶鍒剁殑鍦板崁銆�
閬╃敤浜庣劇鑿屾妧琛撳煿瑷擄紝鎿嶄綔閬庣▼椹楄瓑锛岄亷鏈熻ō缃拰缍鐢㈠搧璩噺鐨勪竴閮ㄥ垎锛岄殧闆㈠櫒绯荤当鏄竴鍊嬫湁鏁堢殑瑙ｆ焙鏂规锛岀壒鍒ユ槸浣庨噺鐨勫埗钘ユ搷浣溿€傚湪娓涘皯缍撶嚐鍜岃淇垚鏈殑鍚屾檪锛屽叾闅旈洟鍣ㄥ崰鐢ㄦ洿灏戠殑绌洪枔锛屼互鍙婃槗浜庣董璀枫€�
Isoclean 闅旈洟寮忓埗钘ユ搷浣滃畨鍏ㄦ煖锛堣矤澹撳瀷锛夐仼鐢ㄤ簬娑夊強鍗遍毆鏉愭枡锛屾姉鑵槫锛屾垨绱拌優姣掓€х殑鍒惰棩鎳夌敤銆傚伐浣滃崁鍜岄€氶亷浜ゆ彌鍗€閮芥槸鍦ㄨ矤澹撳姏鐨勬儏娉佷笅閬嬩綔锛屽湪灞忛殰闅旈洟绯荤当鏁呴殰鐨勬儏娉佷笅纰轰繚瀹夊叏鏌滃収鏄劇鑿岀殑锛屼互淇濊鎿嶄綔鑰呯殑瀹夊叏銆�
* United States Pharmacopoeia (USP), Chapter 797(1), enacted January 1, 2004, presents the first enforceable standards for sterile compounding. Following years of patient safety recommendations and professional guidelines, the intent of USP 797 is to set forth the procedural and practical requirements for safe compounding of sterile preparations. The Chapter's requirements are applicable in all practice settings where sterile preparations are compounded.
鏍稿績鍎嫝锛�
- ISO 娼斿噲搴︽婧�3绱氬伐浣滃崁
- 楂樼礆鎿嶄綔鑰呬繚璀�
- 蹇€熷惞鎺冩檪闁�
- 姗熷嫊楂樺害鏀灦
- 绗﹀悎USP 797 瑕忔牸
鍦板潃锛氳タ瀹夊競澶櫧鍗楄矾5铏熺传钖囧皻灞よタ涓€妯撲竴鍠厓1407瀹CP鍌欙細